Cargando…

Therapeutic Potential of Mesenchymal Stem Cells in a Pre-Clinical Model of Diabetic Kidney Disease and Obesity

Diabetic kidney disease (DKD) is a worldwide microvascular complication of type 2 diabetes mellitus (T2DM). From several pathological mechanisms involved in T2DM-DKD, we focused on mitochondria damage induced by hyperglycemia-driven reactive species oxygen (ROS) accumulation and verified whether mes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sávio-Silva, Christian, Soinski-Sousa, Poliana E., Simplício-Filho, Antônio, Bastos, Rosana M. C., Beyerstedt, Stephany, Rangel, Érika Bevilaqua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913657/ https://www.ncbi.nlm.nih.gov/pubmed/33557007 http://dx.doi.org/10.3390/ijms22041546

Ejemplares similares

Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
por: Sávio-Silva, Christian, et al.
Publicado: (2020)

Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease
por: Franco, Marcella Liciani, et al.
Publicado: (2021)

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
por: Beyerstedt, Stephany, et al.
Publicado: (2021)

Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes Mellitus, Obesity and Diabetic Kidney Disease
por: Bastos, Rosana M. C., et al.
Publicado: (2022)

Mesenchymal Stem Cells as Therapeutic Candidates for Halting the Progression of Diabetic Nephropathy
por: Paulini, Janaina, et al.
Publicado: (2016)

Antimicrobial oral lavage reduces the SARS-CoV-2 load in intubated patients: randomized clinical trial
por: Bezinelli, Letícia Mello, et al.
Publicado: (2022)

Gut microbiota-derived metabolites are novel targets for improving insulin resistance
por: Bastos, Rosana MC, et al.
Publicado: (2022)

Excessive cholecalciferol supplementation increases kidney dysfunction associated with intrarenal artery calcification in obese insulin-resistant mice
por: Almeida, Youri E., et al.
Publicado: (2020)

Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study
por: de Lucena, Débora Dias, et al.
Publicado: (2020)

Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases
por: Hu, Chenxia, et al.
Publicado: (2019)

Hyperkalemia in Diabetes Mellitus Setting
por: Goia-Nishide, Kleber, et al.
Publicado: (2022)

Hypokalemia in Diabetes Mellitus Setting
por: Coregliano-Ring, Lucas, et al.
Publicado: (2022)

Mesenchymal stem cells: A new therapeutic tool for chronic kidney disease
por: Wang, Jiali, et al.
Publicado: (2022)

Stem Cell Applications in Regenerative Medicine for Kidney Diseases
por: Rangel, Érika B., et al.
Publicado: (2021)

The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice
por: jaber, Hala, et al.
Publicado: (2021)

Cellular senescence, a novel therapeutic target for mesenchymal stem cells in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2020)

Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential
por: Alvites, Rui, et al.
Publicado: (2022)

Targeting Murine Mesenchymal Stem Cells to Kidney Injury Molecule‐1 Improves Their Therapeutic Efficacy in Chronic Ischemic Kidney Injury
por: Zou, Xiangyu, et al.
Publicado: (2018)

Potential pre-activation strategies for improving therapeutic efficacy of mesenchymal stem cells: current status and future prospects
por: Li, Meirong, et al.
Publicado: (2022)

Obesity impairs cardiolipin-dependent mitophagy and therapeutic intercellular mitochondrial transfer ability of mesenchymal stem cells
por: Sagar, Shakti, et al.
Publicado: (2023)

Mesenchymal Stem Cells as Therapeutic Agents and Novel Carriers for the Delivery of Candidate Genes in Acute Kidney Injury
por: Liu, Yuxiang, et al.
Publicado: (2020)

Mesenchymal Stem Cell-Derived Extracellular Vesicles: A Potential Therapeutic Strategy for Acute Kidney Injury
por: Li, Jia-Kun, et al.
Publicado: (2021)

Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease
por: Cao, Qinghua, et al.
Publicado: (2022)

Effects of Obesity on Reparative Function of Human Adipose Tissue-Derived Mesenchymal Stem Cells on Ischemic Murine Kidneys
por: Klomjit, Nattawat, et al.
Publicado: (2022)

Author Correction: The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice
por: jaber, Hala, et al.
Publicado: (2021)

Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities
por: Salgado, Antonio J., et al.
Publicado: (2015)

Identifying the Therapeutic Significance of Mesenchymal Stem Cells
por: Mishra, Vineet Kumar, et al.
Publicado: (2020)

Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke
por: Zhang, Yuchen, et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis
por: Mohamad Yusoff, Farina, et al.
Publicado: (2023)

Pre-vascularization Enhances Therapeutic Effects of Human Mesenchymal Stem Cell Sheets in Full Thickness Skin Wound Repair
por: Chen, Lei, et al.
Publicado: (2017)

Obesity and Wound Healing: Focus on Mesenchymal Stem Cells
por: Alma, Antonio, et al.
Publicado: (2023)

Adipokines at the crossroads of obesity and mesenchymal stem cell therapy
por: Pham, Duc-Vinh, et al.
Publicado: (2023)

Progenitor/Stem Cell Delivery by Suprarenal Aorta Route in Acute Kidney Injury
por: Rangel, Érika B., et al.
Publicado: (2019)

Synovial fluid and synovial membrane mesenchymal stem cells: latest discoveries and therapeutic perspectives
por: de Sousa, Eduardo Branco, et al.
Publicado: (2014)

Potential and Therapeutic Efficacy of Cell-based Therapy Using Mesenchymal Stem Cells for Acute/chronic Kidney Disease
por: Yun, Chul Won, et al.
Publicado: (2019)

Mesenchymal stem cell-based therapy in kidney transplantation
por: Chen, Cheng, et al.
Publicado: (2016)

Use of mesenchymal stem cells for chronic kidney disease
por: Chung, Byung Ha
Publicado: (2019)

Mesenchymal Stem Cells—Potential Applications in Kidney Diseases
por: Bochon, Benjamin, et al.
Publicado: (2019)

Anti-obesity effect and mechanism of mesenchymal stem cells influence on obese mice
por: Xie, Zongyan, et al.
Publicado: (2021)

The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD
por: de Sá, João Roberto, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_01lb605jpplheskuhmvfudmfv4